Vaccine Processing Materials From BSE Countries To Be Removed By 2001
Executive Summary
Bovine-derived materials used in vaccine manufacturing will be sourced only from countries determined to be free of bovine spongiform encephalopathy within the next year, FDA Office of Vaccines Research & Review Acting Director William Egan, PhD, said July 27.